An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxy ethyl starch

BMC Blood Disorders

Volumn 5, Issue , 2005, Pages

  Engström, Martin ^a   Reinstrup, Peter ^a   Schött, Ulf ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HALMSTAD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DILUTION; DRUG EFFECT; DRUG MONITORING; HUMAN; IN VITRO STUDY; INTERNATIONAL NORMALIZED RATIO; PROTHROMBIN TIME; STANDARD; THROMBOELASTOGRAPHY; VOLUNTEER;

EID: 27544434477     PISSN: 14712326     EISSN: 14712326     Source Type: Journal    
DOI: 10.1186/1471-2326-5-3     Document Type: Article

References (28)

1. Counts RB, Haisch C, Simon TL, Maxwell NG, Heimbach DM, Carrico CJ: Hemostasis in massively transfused trauma patients. Ann Surg 1979, 190:91-99.
2. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, Hoyt DB: Lethal injuries and time to death in a level I trauma Center.J Am Coll Surg 1998, 186:528-533.
3. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT: Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38:185-193.
4. Kenet G, Walden R, Eldad A, Martinowitz U: Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999, 354:1879.
5. Dutton RP, Hess JR, Scalea TM: Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 2003, 15:184-188.
6. Tobias JD: Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children. Anesthesiology 2002, 96:1522-1525.
7. Martinowitz U, Kenet G, Segal E, Luboshitz J. Lubetsky A, Ingerslev J, Lynn M: Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001, 51:431-8; discussion 438-9.
8. Petroianu GA, Liu J, Maleck WH, Mattinger C, Bergler WF: The effect of In vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph. Anesth Analg 2000, 90:795-800.
9. Niemi TT, Kuitunen AH: Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998, 42:1104-1109.
10. Ekseth K, Abildgaard L, Vegfors M, Berg-Johnsen J., Engdahl O: The in vitro effects of crystalloids and colloids on coagulation, Anaesthesia 2002, 57:1102-1108.
11. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T Spahn DR: Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 20U/U.5 using thrombelastography. Anesth Analg 1998, 87:989-993.
12. Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR: Coagulaticn effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000, 44:1116-1121.
13. Aldouri M: The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb, 2002, 32 Suppl 1:41-46.
14. Aucar JA, Norman P, Whitten E, Granchi TS, Liscum KR, Wall MJ, Mattox KL: Intraoperatiye detection of traumatic coagulopathy using the activated coagulation time. Shock 2003, 19:404-407.
15. Garrison JR Richardson JD, Hilakos AS, Spain DA, Wilson MA, Miller FB, Fulton RL: Predicting the need to pack early for severe intra-abdominal hemorrhage. J Trauma 1996, 40:923-7; discussion 927-9.
16. Keller MS, Fendya DC, Weber TR: Glasgow Coma Scale predicts coagulopathy in pediatric trauma patients. Semin Pediatr Surg 2001, 10:12-16.
17. Hendriks HG Meijer K, de Wolf JT, Porte RJ, Klompmaker IJ, Lip H, Slooff MJ,, van der Meer J: Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis 2002, 13:309-313.
18. Ingerslev J, Christiansen K, Calatzis A, Holm M, Sabroe Ebbesen L: Management and monitoring of recombinant activated factor VII. Blood Coagul Fibrinolysis 2000, II Suppl 1:S25-30.
19. Sorensen B, Ingerslev J: Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Semin Hematol 2004, 41:140-144
20. Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR: In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT. Anesth Analg 2000, 90:274-279.
21. Erhardtsen E, Nony P, Dechavanne M, Ffrench P, Boissel JP, Hedner U: The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis 1998, 9:741-748,
22. Deveras RA, Kessler CM: Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002, 137:884-888.
23. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U: Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 2002, 28 Suppl 2:S241-7.
24. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J: Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003, 1:551-558.
25. Poon MC, d'Oiron R, Hann I, Negrier C, de Lumley L, Thomas A, Karafoulidou A, Demers C, Street A, Huth-Kuhne A, Petrini P, Fressinaud E, Morfini M, Tengborn L, Marques-Verdier A, Musso R, Devecioglu O, Houston DS, Lethagen S, Van Geet C, von Depka M, Berger C, Beurrier P, Britton HA, Gerrits W, Guthner C, Kuhle S, Lorenzo JJ, Makris PE, Nohe N, Paugy P, Pautard B, Torchet MF, Trillot N, Vicariot M, Wilde J, Winter M, Chambost H, Ingerslev J, Peters M, Strauss G: Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 2001. 38:21-25.
26. Caglar K, Cetinkaya A, Aytac S, Gumruk F, Gurgey A: Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Pediatr Hematol Oncol 2003, 20:435-438.
27. Poon MC: Use of recombinant factor VIIa in hereditary bleeding disorders. Curr Opin Hematol 2001, 8:312-318.
28. d'Oiron R, Menart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Negrier C: Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 2000, 83:644-647.